|
Mechanism50S subunit inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date01 Jan 1989 |
100 Clinical Results associated with Refarmed Chemicals (India) Pvt Ltd.
0 Patents (Medical) associated with Refarmed Chemicals (India) Pvt Ltd.
100 Deals associated with Refarmed Chemicals (India) Pvt Ltd.
100 Translational Medicine associated with Refarmed Chemicals (India) Pvt Ltd.